GenomeQuest is sponsoring an award program that will provide bioinformatics support to clinical labs that want to transition to next-generation sequencing.
The company said it will award the grants to five labs who are looking to consolidate multiple Sanger-based diagnostic tests into a single NGS-based test.
Labs that are awarded the grants, which the company values at $20,000 each, will receive all the software, annotation data, and compute infrastructure required to process and store patient sequence data, produce tailored diagnostic reports, and perform follow-up research on aggregated results, according to the company.
To qualify for the grant, labs must operate a medical diagnostic lab that is listed under the National Center for Biotechnology Information's GeneTests website and also be committed to transitioning to NGS-based testing.
Applications are due Dec. 1 and the awards will be announced Dec. 15. Further information about the program is available on GenomeQuest's website.